This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Julius-Maximilians-Universitat Wurzburg. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Ralf Bargou: Innovator in Antiinfective and Antitumoral Compounds
Introduction
Ralf Bargou is a notable inventor based in Höchberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in treating infections and tumors. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Ralf Bargou holds a patent for "Antiinfective and antitumoral compounds isolated from tropical lianas." This invention relates to naphthoquinone derivatives that are isolated from solid callus cultures of two species from the palaeotropical plant families Dioncophyllaceae and Ancistrocladaceae. The patent outlines methods for producing these compounds and their use as antiinfective and antitumoral pharmaceuticals. He has 1 patent to his name, reflecting his innovative contributions to the field.
Career Highlights
Bargou is affiliated with Julius Maximilians University of Würzburg, where he continues to engage in research and development. His work at the university allows him to collaborate with other experts in the field and contribute to groundbreaking research that has the potential to impact public health.
Collaborations
Ralf Bargou has worked alongside notable colleagues such as Gerhard Bringmann and Stefan Rüdenauer. These collaborations have enriched his research and have been instrumental in the development of his patented compounds.
Conclusion
Ralf Bargou's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to addressing critical health challenges. His work not only highlights the importance of research in developing new treatments but also showcases the potential of natural compounds in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
